Related Experiment Video
Updated: Apr 5, 2026

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
Published on: August 26, 2013
The Bone Morphogenetic Proteins and Their Antagonists
Barbara Mulloy1, Chris C Rider1
1Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway, University of London, Egham, Surrey, United Kingdom.
Abstract:
The bone morphogenetic proteins (BMPs) and the growth and differentiation factors comprise a single family of some 20 homologous, dimeric cytokines which share the cystine-knot domain typical of the TGF-β superfamily. They control the differentiation and activity of a range of cell types, including many outside bone and cartilage. They serve as developmental morphogens, but are also important in chronic pathologies, including tissue fibrosis and cancer. One mechanism for enabling tight spatiotemporal control of their activities is through a number of antagonist proteins, including Noggin, Follistatin, Chordin, Twisted gastrulation (TSG), and the seven members of the Cerberus and Dan family. These antagonists are secreted proteins that bind selectively to particular BMPs with high affinity, thereby blocking receptor engagement and signaling. Most of these antagonists also possess a TGF-β cystine-knot domain. Here, we discuss current knowledge and understanding of the structures and activities of the BMPs and their antagonists, with a particular focus on the latter proteins. Recent advances in structural biology of BMP antagonists have begun the process of elucidating the molecular basis of their activity, displaying a surprising variety between the modes of action of these closely related proteins. We also discuss the interactions of the antagonists with the glycosaminoglycan heparan sulfate, which is found ubiquitously on cell surfaces and in the extracellular matrix.
Insights
Bone morphogenetic proteins (BMPs) regulate cell activity and development. Their antagonists, like Noggin and Chordin, control BMP signaling through high-affinity binding, with diverse molecular mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Developmental Biology
Background:
- Bone morphogenetic proteins (BMPs) are a family of cytokines crucial for cell differentiation and activity.
- BMPs act as morphogens in development and are implicated in pathologies like fibrosis and cancer.
- Antagonist proteins, including Noggin, Follistatin, Chordin, TSG, and the Cerberus/Dan family, regulate BMP signaling.
Purpose of the Study:
- To review current knowledge on the structures and activities of BMPs and their antagonists.
- To focus on the molecular mechanisms and structural biology of BMP antagonists.
- To explore the interactions between BMP antagonists and heparan sulfate.
Main Methods:
- Review of existing literature on BMPs and their antagonists.
- Analysis of structural biology data for BMP antagonists.
- Discussion of biochemical interactions and signaling pathways.
Main Results:
- BMP antagonists exhibit diverse modes of action despite structural similarities.
- High-affinity binding of antagonists to specific BMPs blocks receptor engagement.
- Antagonists often share the TGF-β superfamily cystine-knot domain with BMPs.
Conclusions:
- Structural biology advances are revealing the varied molecular basis of BMP antagonist activity.
- Understanding these antagonists is key to controlling BMP signaling in development and disease.
- Heparan sulfate interactions represent another layer of BMP antagonist regulation.
Related Concept Videos
TGF - β Signaling Pathway
Bone Remodeling and Repair
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Matrix Metalloproteases in Degradation of ECM

